Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Sdmsdmon Aug 21, 2015 6:17am
221 Views
Post# 24038843

RE:RE:RE:RE:why i have over 300,000 shares

RE:RE:RE:RE:why i have over 300,000 sharesInteresting that there is relatively little information on their website about the generics they sell (in fact the site reads more like a fan site for Louis Pilon their CEO). They have an extensive portfolio (verified by looking at HC database) but difficult to draw conclusions on the overall size of market they are targeting with their products. Around 100 employees and $50m sales so certainly well established. 

I emailed the company (Vanc) yesterday requesting that they provide a corporate update (its been 3 months since the last one) but have yet to receive a reply. 

I think we are just suffering from a thin market and hope this will start to pick up in September. Think there might be an opportunity for some more cheap shares over the coming 10 days though. 

Good luck all. 

SDM
Bullboard Posts